HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Edward J Cupler Selected Research
Edward J Cupler Research Topics
Disease
2
COVID-19
01/2022 - 06/2021
2
Glycogen Storage Disease Type II (Pompe's Disease)
10/2015 - 03/2012
1
Multiple Sclerosis
01/2022
1
Infections
06/2021
1
Myasthenia Gravis
12/2010
1
Acute Kidney Injury (Acute Renal Failure)
06/2010
1
Nephrogenic Fibrosing Dermopathy
06/2010
1
Renal Insufficiency (Renal Failure)
06/2010
1
Macrophagic myofasciitis
06/2008
1
Myositis (Idiopathic Inflammatory Myopathies)
06/2008
1
Granuloma
06/2008
Drug/Important Bio-Agent (IBA)
2
teriflunomide
IBA
01/2022 - 06/2021
2
alpha-Glucosidases (Acid Maltase)
IBA
10/2015 - 03/2012
2
Enzymes
IBA
10/2015 - 03/2012
2
Glycogen
IBA
10/2015 - 03/2012
1
Pharmaceutical Preparations
IBA
01/2022
1
siponimod
IBA
06/2021
1
Natalizumab (Tysabri)
FDA Link
06/2021
1
Alemtuzumab (Campath)
FDA Link
06/2021
1
Tablets
IBA
06/2021
1
ocrelizumab
IBA
06/2021
1
Interferon-beta
IBA
06/2021
1
Cladribine
FDA Link
Generic
06/2021
1
Fingolimod Hydrochloride (FTY720)
FDA Link
06/2021
1
Dimethyl Fumarate
IBA
06/2021
1
Acids
IBA
03/2012
1
Antibodies
IBA
12/2010
1
Cholinergic Receptors
IBA
12/2010
1
Rituximab (Mabthera)
FDA Link
12/2010
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
12/2010
1
Gadolinium
IBA
06/2010
1
Periodic Acid
IBA
06/2008
1
Vaccines
IBA
06/2008
1
Aluminum Hydroxide (Algeldrate)
FDA Link
06/2008
Therapy/Procedure
2
Therapeutics
06/2021 - 12/2010
1
Enzyme Replacement Therapy
03/2012